Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Robert LeBoyer is an analyst at Noble Capital Markets. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/26/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/20/2025 | TNXP | Buy Now | Tonix Pharmaceuticals | $29.25 | 139.32% | Robert LeBoyer47% | $70 → $70 | Reiterates | Outperform → Outperform | Get Alert |
| 01/22/2025 | NTRB | Buy Now | Nutriband | $6.85 | 89.81% | Robert LeBoyer47% | → $13 | Initiates | → Outperform | Get Alert |
| 08/19/2024 | GOVX | Buy Now | Geovax Labs | $1.40 | 614.29% | Robert LeBoyer47% | $6 → $10 | Maintains | Outperform | Get Alert |
| 02/14/2024 | UNCY | Buy Now | Unicycive Therapeutics | $0.63 | 852.38% | Robert LeBoyer47% | → $6 | Initiates | → Outperform | Get Alert |
| 12/18/2023 | CVKD | Buy Now | Cadrenal Therapeutics | $19.96 | -79.96% | Robert LeBoyer47% | → $60 | Initiates | → Outperform | Get Alert |
| 09/27/2023 | ELDN | Buy Now | Eledon Pharma | $3.49 | 186.53% | Robert LeBoyer47% | → $10 | Initiates | → Outperform | Get Alert |
| 05/08/2023 | GOVX | Buy Now | Geovax Labs | $1.40 | 328.57% | Robert LeBoyer47% | → $90 | Initiates | → Outperform | Get Alert |
| 02/21/2023 | MAIA | Buy Now | MAIA Biotechnology | $1.57 | 791.72% | Robert LeBoyer47% | → $14 | Initiates | → Outperform | Get Alert |
| 09/20/2022 | AYLA | Buy Now | Ayala Pharmaceuticals | — | — | Robert LeBoyer47% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 04/18/2022 | TNXP | Buy Now | Tonix Pharmaceuticals | $29.25 | -97.95% | Robert LeBoyer47% | → $384000 | Initiates | → Outperform | Get Alert |
| 10/12/2021 | AXLA | Buy Now | Axcella Health | — | — | Robert LeBoyer47% | → $150 | Initiates | → Outperform | Get Alert |
| 08/19/2021 | LCTX | Buy Now | Lineage Cell Therapeutics | $0.52 | 1438.17% | Robert LeBoyer47% | → $8 | Initiates | → Outperform | Get Alert |
| 01/25/2021 | PSTV | Buy Now | Plus Therapeutics | $1.35 | 492.33% | Robert LeBoyer47% | → $120 | Initiates | → Buy | Get Alert |
| 10/05/2020 | BNTC | Buy Now | Benitec Biopharma | $14.19 | — | Robert LeBoyer47% | — | Downgrade | Buy → Neutral | Get Alert |
| 09/28/2020 | AVXL | Buy Now | Anavex Life Sciences | $9.51 | 26.22% | Robert LeBoyer47% | → $12 | Initiates | → Buy | Get Alert |
| 09/17/2020 | LCTX | Buy Now | Lineage Cell Therapeutics | $0.52 | — | Robert LeBoyer47% | — | Initiates | → Outperform | Get Alert |
| 08/24/2020 | CNSP | Buy Now | CNS Pharma | $1.63 | 574.85% | Robert LeBoyer47% | → $825000 | Initiates | → Buy | Get Alert |
| 04/10/2018 | VTVT | Buy Now | vTv Therapeutics | $16.70 | — | Robert LeBoyer47% | — | Downgrade | Buy → Neutral | Get Alert |
| 03/08/2018 | NTRP | Buy Now | Neurotrope | $5.92 | 153.38% | Robert LeBoyer47% | → $15 | Initiates | → Buy | Get Alert |
| 04/12/2017 | NTRP | Buy Now | Neurotrope | $5.92 | 423.66% | Robert LeBoyer47% | → $31 | Initiates | → Buy | Get Alert |
